Skip to main content
. 2022 Jun 21;13:920436. doi: 10.3389/fphar.2022.920436

FIGURE 8.

FIGURE 8

The representative chromatograms of lenvatinib (Ⅰ), sorafenib (Ⅱ), cabozantinib (Ⅲ), regorafenib (Ⅳ), apatinib (Ⅴ), gefitinib (Ⅵ), anlotinib (Ⅶ), tivantinib (Ⅷ), galunisertib (Ⅸ), and IS (Ⅹ) in blank plasma samples (A); each analyte in LLOQ samples (B).